Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
4 Visualizações
administrator
07/30/23
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
Mostre mais
Comentários do Facebook
Nenhum comentário encontrado